- Home
- STSS
as 11-22-2024 4:00pm EST
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes are designed to eliminate potentially infectious and accidental needlestick injuries.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | MELVILLE |
| Market Cap: | 5.1M | IPO Year: | 2022 |
| Target Price: | N/A | AVG Volume (30 days): | 63.4K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -7.92 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.34 - $18.15 | Next Earning Date: | 11-14-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Sharps Technology Inc. News
STSS Breaking Stock News: Dive into STSS Ticker-Specific Updates for Smart Investing
MT Newswires
5 days ago
Sharps Technology Regains Compliance With Nasdaq Minimum Bid Price Rule
GlobeNewswire
5 days ago
Sharps Regains Nasdaq Listing Compliance
GlobeNewswire
a month ago
Sharps Technology, Inc. Announces Stockholders’ Approval of Reverse Stock Split Ratio and Effective Date
GuruFocus.com
a month ago
Empery Asset Management's Strategic Reduction in Sharps Technology Inc
GlobeNewswire
2 months ago
Sharps Technology, Inc. Reminds Shareholders to Vote Before Important Shareholder Meeting on October 7, 2024
ACCESSWIRE
2 months ago
Aegis Capital Corp. Acted as Exclusive Placement Agent on a $3.5 Million Bridge Financing for Sharps Technology, Inc. (NASDAQ:STSS)
MT Newswires
2 months ago
Sharps Technology Closes $3.5 Million Bridge Financing
GlobeNewswire
2 months ago
Sharps Technology, Inc. Closes $3.5 Million Bridge Financing
Compare STSS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "STSS Sharps Technology Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.